Sun-Young Ryu

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder et al. · Journal of Clinical Oncology · 2021 · 183 citations · Full text

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

Alison J. Moskowitz, Paola Ghione, Eric D. Jacobsen et al. · Blood · 2021 · 159 citations · Full text

1α,25-Dihydroxyvitamin D3 Protects Dopaminergic Neurons in Rodent Models of Parkinson's Disease through Inhibition of Microglial Activation

Joong‐Seok Kim, Sun-Young Ryu, Injin Yun et al. · Journal of Clinical Neurology · 2006 · 56 citations · Full text

ILC Reference Design Report Volume 3 - Accelerator

R. Erbacher, T. Mimashi, Jin‐Young Jung et al. · arXiv (Cornell University) · 2007 · 40 citations · Full text

International Linear Collider, Electrical Engineering, Peak Luminosity +15

ILC Reference Design Report: ILC Global Design Effort and World Wide Study

J. E. Brau, T. Mimashi, Jin‐Young Jung et al. · (2007) · 2007 · 35 citations

Architectural Design, Integrated Design, Design Evaluation +5